Patent directory · USPTO A61K / A61P
Patents matching “bupropion”
16 pharma patents match "bupropion" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 16 pharmaceutical patents matching "bupropion" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12357697
Pharmaceutical compositions comprising bupropion and cysteine
granted -
US 12156914
Pharmaceutical compositions comprising bupropion and cysteine
granted -
US 12102606
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
US 11786488
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
US 11660274
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
US 11433035
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
US 11344514
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
US 11344513
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
US 11331285
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
US 11291639
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
US 11179351
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
US 11179352
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
US 11129826
Bupropion as a modulator of drug activity
granted -
US 11123344
Bupropion as a modulator of drug activity
granted -
US 10695304
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
US 6306436
Stabilized, acid-free formulation for sustained release of bupropion hydrochloride
expired